MHRA — authorised 8 February 2018
- Marketing authorisation holder: Novo Nordisk A/S
- Status: approved
🇬🇧 Ozempic in United Kingdom
MHRA authorised Ozempic on 8 February 2018 · NICE has issued 3 UK HTA decisions
Marketing authorisation
Health technology assessment
3 decisions from NICE for Ozempic in United Kingdom.
NICE TA1152 — — Decision pending classification
- Indication assessed: reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity
NICE has recommended Ozempic for the indication of reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity. This decision was made based on a commercial arrangement. No restriction or condition was specified in the decision.
NICE TA875 — ✓ Recommended
- Indication assessed: managing overweight and obesity
NICE recommended Ozempic for managing overweight and obesity. This decision was made without a reported ICER, indicating that the cost-effectiveness was not a determining factor. There is a commercial arrangement in place, but no Patient Access Scheme.
NICE TA910 — — Appraisal terminated
- Indication assessed: managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal)
NICE made a decision to terminate the appraisal of Ozempic for managing overweight and obesity in young people aged 12 to 17 years. This decision means that the appraisal process for this indication has been stopped. The decision was made without a recommendation on the cost-effectiveness of the drug, as the appraisal was terminated.
Ozempic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United Kingdom
Frequently asked questions
Is Ozempic approved in United Kingdom?
Yes. MHRA authorised it on 8 February 2018.
Who is the marketing authorisation holder for Ozempic in United Kingdom?
Novo Nordisk A/S holds the UK marketing authorisation.
Has Ozempic been assessed by UK health technology agencies?
Yes — 3 UK HTA decisions on record from NICE.